Neurones (NRO) Q2 2026 TU earnings summary

Executive summary

• Organic growth accelerated to 8% in Q2 2026, with strong performance in data, digital projects, ITSM, and Business Process Management.

• Agentic AI rollout advanced through both client projects and internal process optimization.

Financial highlights

• Q2 2026 revenues reached €227.1M, up 8.0% year-over-year, all organic.

• H1 2026 revenues totaled €454.8M, a 7.2% increase year-over-year, with 6.9% organic growth.

• Operating profit for H1 2026 was 8.7% of revenue, up from 7.8% in H1 2025.

Outlook and guidance

• Full-year revenue forecast raised to over €900M.

• Operating profit margin guidance confirmed at approximately 9%.